Feb 25
Scaling AI in Drug Discovery: Architectural Limits and Systemic Risk
AI-driven drug discovery refers to the application of machine learning and statistical inference techniques to support hypothesis generation
A thought leadership perspective on scaling AI-driven drug discovery programs while addressing architectural bottlenecks, data complexity, and operational risk.
#scalable AI drug discovery platforms#research data throughput optimization#pharmaceutical data lifecycle management#AI infrastructure resilience#bioinformatics scalability framework#enterprise life sciences IT modernization#AI model governance healthcare research#high throughput computational research#regulated scientific data systems
